VanEck ETF Trust - VanEck Biotech ETF (SNSE:BBHCL) - Stock Price, News & Analysis

BBHCL Stock Overview

An exchange traded fund launched and managed by Van Eck Associates Corporation.

BBHCL fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

VanEck ETF Trust - VanEck Biotech ETF Competitors

Price History & Performance

Summary of all time highs, changes and price drops for VanEck ETF Trust - VanEck Biotech ETF
Historical stock prices
Current Share Price	US$136,730.00
52 Week High	US$168,000.00
52 Week Low	US$153,000.00
Beta	0
1 Month Change	0%
3 Month Change	0%
1 Year Change	0%
3 Year Change	74.46%
5 Year Change	74.46%
Change since IPO	80.39%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	BBHCL	CL Capital Markets	CL Market
7D	0%	-0.8%	-0.1%
1Y	0%	11.4%	19.0%

Return vs Industry: BBHCL underperformed the CL Capital Markets industry which returned 11.4% over the past year.

Return vs Market: BBHCL underperformed the CL Market which returned 19% over the past year.

Price Volatility

Is BBHCL's price volatile compared to industry and market?
BBHCL volatility
BBHCL Average Weekly Movement	0%
Capital Markets Industry Average Movement	3.2%
Market Average Movement	3.2%
10% most volatile stocks in CL Market	5.4%
10% least volatile stocks in CL Market	1.3%

Stable Share Price: BBHCL has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine BBHCL's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1999	n/a	n/a	www.vaneck.com/us/en/investments/biotech-etf-bbh/

VanEck ETF Trust - VanEck Biotech ETF is an exchange traded fund launched and managed by Van Eck Associates Corporation. The fund invests in public equity markets of the United States. It invests in stocks of companies operating across health care, pharmaceuticals, biotechnology and life sciences, biotechnology sectors.

VanEck ETF Trust - VanEck Biotech ETF Fundamentals Summary

How do VanEck ETF Trust - VanEck Biotech ETF's earnings and revenue compare to its market cap?
BBHCL fundamental statistics
Market cap	CL$404.85b
Earnings (TTM)	CL$0
Revenue (TTM)	n/a

n/a

P/E Ratio

n/a

P/S Ratio

Is BBHCL overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BBHCL income statement (TTM)
Revenue	CL$0
Cost of Revenue	CL$0
Gross Profit	CL$0
Other Expenses	CL$0
Earnings	CL$0

Last Reported Earnings

n/a

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did BBHCL perform over the long term?

See historical performance and comparison